Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



BRISTOL-MYERS SQUIBB COMPANY Stock Hits Target Forecast with 13.0% Profit - QuantWave Analysis

May 14, 2025
On April 11, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price of $50.05. The prediction was spot on as on May 14, 2025, the stock reached the target price of $43.55, resulting in a profit of 13.0% for investors.

This successful forecast highlights the accuracy and effectiveness of QuantWave's analytics in predicting stock movements. Market analysis suggests that factors such as changes in the pharmaceutical industry landscape, company performance, and overall market conditions may have contributed to the stock's movement, aligning with QuantWave's forecast.

For investors seeking reliable forecasts and potential profits, QuantWave offers a wide range of stock predictions through its platform. By leveraging the power of automated forecasting, users can make informed investment decisions to maximize returns. Additionally, for a comprehensive understanding of QuantWave's investment strategy, exploring QuantSchool's educational resources is recommended. QuantSchool provides insights into the key principles for generating consistent income using the QuantWave forecasting system.

Overall, the achievement of the price target forecast for BRISTOL-MYERS SQUIBB COMPANY exemplifies the capabilities of QuantWave in delivering accurate predictions and opportunities for financial gains in the stock market.
If you want to leave a comment, then you need Login or Register





Other data for BMY

Related data

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Stock Hits Price Target with 9.09% Profit: QuantWave Forecast Success  ~2 min.

On April 23, 2025, QuantWave's forecasting platform generated a short signal for BRISTOL-MYERS SQUIBB COMPANY stock, which was trading at $47.9 at the time....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 12.75% Profit - QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY recently achieved the price target forecast set by QuantWave, resulting in a profitable outcome of 12.75%....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.87% Profit  ~1 min.

On May 5, 2025, QuantWave issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.41. The forecast proved accurate as the price target of $43....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 11.76% Profit  ~1 min.

On April 15, 2025, QuantWave, the automated forecasting platform, issued a short signal for BRISTOL-MYERS SQUIBB COMPANY when the stock was trading at $49.35....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 10.38% Profit: QuantWave Analysis  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY, a renowned pharmaceutical company, recently achieved its price target forecast set by QuantWave's automated forecasting platform....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target Forecast with 14.06% Profit  ~1 min.

On April 14, 2025, QuantWave's forecast signal indicated a short position for BRISTOL-MYERS SQUIBB COMPANY stock, which was priced at 50.67 $....

NVOJanuary 31, 2024NOVO NORDISK A/S Hits Price Target Forecast with 11.64% Profit, Showcasing QuantWave's Accuracy  ~1 min.

NOVO NORDISK A/S recently reached the price target forecast set by QuantWave on 2023-11-21, signaling a long position at $100.05. On 2024-01-31, the stock hit the target price of $111....

LLYJune 7, 2024ELI LILLY AND COMPANY Hits Price Target Forecast with 35.45% Profit, Reflecting QuantWave's Accuracy  ~2 min.

ELI LILLY AND COMPANY, a leading pharmaceutical company, recently achieved the price target forecast set by QuantWave with impressive results....

REGNAugust 13, 2024REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 19.03% Profit – QuantWave Success Story  ~2 min.

REGENERON PHARMACEUTICALS, INC. (NASDAQ: REGN) has recently achieved its price target forecast as predicted by the automated forecasting platform, QuantWave....

GSKFebruary 5, 20259.43% Profit Achieved: GSK PLC Hits Price Target Forecast on QuantWave  ~1 min.

On December 11, 2024, QuantWave's automated forecasting platform issued a long signal for GSK PLC with a price of $33.69....

LLYMay 3, 2023ELI LILLY AND COMPANY Hits Price Target Forecast with 18.42% Profit, Reflecting Success of QuantWave Analytics  ~2 min.

ELI LILLY AND COMPANY (LLY) has recently achieved its price target forecast as predicted by the automated forecasting platform QuantWave....